Intrinsic Value of S&P & Nasdaq Contact Us

Edap Tms S.a. EDAP NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • FR • USD

SharesGrow Score
31/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
-39.4%

Edap Tms S.a. (EDAP) generated $-13.95M in operating cash flow for fiscal year 2025. After capital expenditures of $4.86M, free cash flow was $-18.81M.

Free cash flow margin was -26.6% of revenue.

Criteria supported by this page:

  • HEALTH (17/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (39/100, Fail) — limited free cash flow weakens the competitive position

Overall SharesGrow Score: 31/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
31/100
SG Score
View full scorecard →
VALUE
72/100
Price-to-Earnings & upside
→ Valuation
FUTURE
37/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
39/100
Proven by this page
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income
Edap Tms S.a. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $-15.4M$-13.95M$-13.58M$-14.68M$-3.02M
Capital Expenditure $-5.44M$-4.86M$-4.1M$-4.25M$-2.18M
Free Cash Flow $-20.84M$-18.81M$-17.69M$-18.63M$-5.21M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message